中航產融(600705.SH):中航產投擬向新研股份子公司明日宇航增資4億元
格隆匯8月13日丨中航產融(600705.SH)公佈,公司全資子公司中航資本產業投資有限公司(簡稱“中航產投”)擬與德陽發展控股集團有限公司和嘉興華控騰匯股權投資合夥企業(有限合夥)共同對新研股份(300159SZ)的控股子公司四川明日宇航工業有限責任公司(簡稱“明日宇航”)進行股權投資,中航產投與明日宇航簽訂《股權融資之合作意向框架協議》,中航產投擬嚮明日宇航增資人民幣4億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.